Erythropoietin Drugs Market was valued at US$ 10.45 Bn in 2022 and is expected to reach US$ 22.00 Bn by 2029, at a CAGR of 11.22% during a forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Erythropoietin Drugs Market Dynamics
Erythropoietin drugs are also known as hematopoietin that controls erythropoiesis as well as the production of red blood cells. They are used in the treatment of various diseases like cancer, chronic renal diseases, AIDS, anemia, etc. The erythropoietin market is driven by the growing prevalence of chronic diseases like cancer, AIDA, and renal diseases. The introduction of new drugs and different government initiatives for research are also boosting the growth of the market. However, the high cost of treatment, as well as the side effects of the treatment, are limiting the growth of the market.Segment Analysis
Biosimilar is the fastest-growing segment in the erythropoietin drugs market, especially in developing countries, owing to low-cost therapeutics and enhanced efficacy. Biosimilar is easy to change & improve, cost-effective, and requires less time for approval as compared to biologics, and are expected to gain popularity in the near future for the treatment of anemic conditions. In cancer patients, almost 77% suffer from anemia, which is often overlooked as tiredness. Anemia is generally associated with cancer, owing to chemotherapy treatment, blood loss, marrow tumor, nutritional deficiency, but is mostly caused due to cytokine production. Retail pharmacies in the distribution channel segment leads the global market with a huge share. A retail pharmacist provides advice about health issues, symptoms & medications responding to customer inquiries, recruiting, training & managing staff, treating prescriptions & dispensing medication. Retail pharmacies are also preparing publicity materials & displays, managing budgets, and keeping statistical & financial records.Erythropoietin Drugs Market Regional Insights:
North America is leading the largest market, followed by Europe during the forecast period owing to the constantly growing cancer populace and the patient suffering from renal diseases in North America. Technological advances and governmental initiatives for research are also leading the largest market in this region. Increasing purchasing power, rapid growth in infrastructure, rising medical tourism, and expansion in available treatments is increasing the growth of the Asia Pacific region in the market during the forecast period. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market. Global Erythropoietin Drugs Market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Erythropoietin Drugs Market Erythropoietin Drugs Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. Global Erythropoietin Drugs Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global Erythropoietin Drugs Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Erythropoietin Drugs Market are also profiled.Erythropoietin Drugs Market Scope: Inquire before buying
Erythropoietin Drugs Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 10.45 Bn. Forecast Period 2023 to 2029 CAGR: 11.22% Market Size in 2029: US $ 22.00 Bn. Segments Covered: by Drug Class Epoetin Alfa Epoetin Beta Darbepoetin Alfa by Type Biologics Biosimilar by Application Cancer Renal Disease Hematology Neurology Surgery & Wound Healing by Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Erythropoietin Drugs Market Key Players:
1. Amgen 2. Hoffmann-LA Roche 3. Johnson & Johnson 4. Kyowa Hakko Kirin 5. Ahua Pharmaceutical 6. 3SBio 7. BIOSIDUS 8. Biocon 9. Boehringer Ingelheim 10. Chugai Pharmaceutical 11. Celltrion 12. Intas Pharmaceuticals 13. Cipla 14. DAICHI SANKYO 15. Dr. Reddy's Laboratories 16. Teva Pharmaceutical Industries 17. Dragon Pharma 18. Huaxin High Biotechnology 19. JCR Pharmaceuticals 20. Shanghai Kehua Bio-Engineering 21. LG Life Science 22. Novartis 23. Pfizer 24. Sandoz International 25. Shenyang Sunshine Pharmaceutical 26. Shenzhen Sai Bao Er Bio-Pharmaceutical 27. Sihuan Pharmaceutical 28. STADA 29. Uni-Bio Science 30. Wanbang Biochemical Pharmaceuticals Frequently Asked Questions: 1. Which region has the largest share in Global Erythropoietin Drugs Market? Ans: Asia Pacific region holds the highest share in 2022. 2. What is the growth rate of Global Erythropoietin Drugs Market? Ans: The Global Erythropoietin Drugs Market is growing at a CAGR of 11.22% during forecasting period 2023-2029. 3. What is scope of the Global Erythropoietin Drugs Market report? Ans: Global Erythropoietin Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Erythropoietin Drugs Market is studied from 2022 to 2029.
Global Erythropoietin Drugs Market
1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Erythropoietin Drugs Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7 Key Trends in Global Erythropoietin Drugs Market 5. Global Erythropoietin Drugs Market Analysis and Forecast 5.1. Global Erythropoietin Drugs Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Erythropoietin Drugs Market Analysis and Forecast, By Drug Class 6.1. Introduction and Definition 6.2. Global Erythropoietin Drugs Market Value Share Analysis, By Drug Class 6.3. Global Erythropoietin Drugs Market Size (US$ Bn) Forecast, By Drug Class 6.4. Global Erythropoietin Drugs Market Analysis, By Drug Class 6.5. Global Erythropoietin Drugs Market Attractiveness Analysis, By Drug Class 6.6. Key Trends 6.6.1. Key Developments 7. Global Erythropoietin Drugs Market Analysis and Forecast, By Drug Type 7.1. Introduction and Definition 7.2. Global Erythropoietin Drugs Market Value Share Analysis, By Drug Type 7.3. Global Erythropoietin Drugs Market Size (US$ Bn) Forecast, By Drug Type 7.4. Global Erythropoietin Drugs Market Analysis, By Drug Type 7.5. Global Erythropoietin Drugs Market Attractiveness Analysis, By Drug Type 7.6. Key Trends 7.6.1. Key Developments 8. Global Erythropoietin Drugs Market Analysis and Forecast, By Drug Application 8.1. Introduction and Definition 8.2. Global Erythropoietin Drugs Market Value Share Analysis, By Drug Application 8.3. Global Erythropoietin Drugs Market Size (US$ Bn) Forecast, By Drug Application 8.4. Global Erythropoietin Drugs Market Analysis, By Drug Application 8.5. Global Erythropoietin Drugs Market Attractiveness Analysis, By Drug Application 8.6. Key Trends 8.6.1. Key Developments 9. Global Erythropoietin Drugs Market Analysis and Forecast, By Distribution Channel 9.1. Introduction and Definition 9.2. Global Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 9.3. Global Erythropoietin Drugs Market Size (US$ Bn) Forecast, By Distribution Channel 9.4. Global Erythropoietin Drugs Market Analysis, By Distribution Channel 9.5. Global Erythropoietin Drugs Market Attractiveness Analysis, By Distribution Channel 9.6. Key Trends 9.6.1. Key Developments 10. Global Erythropoietin Drugs Market Analysis, by Region 10.1. Global Erythropoietin Drugs Market Value Share Analysis, by Region 10.2. Global Erythropoietin Drugs Market Size (US$ Bn) Forecast, by Region 10.3. Global Erythropoietin Drugs Market Attractiveness Analysis, by Region 10.4. Key Trends 10.4.1. Key Developments 11. North America Erythropoietin Drugs Market Analysis 11.1. Key Findings 11.2. North America Erythropoietin Drugs Market Overview 11.3. North America Erythropoietin Drugs Market Value Share Analysis, By Drug Class 11.4. North America Erythropoietin Drugs Market Forecast, By Drug Class 11.4.1. Epoetin Alfa 11.4.2. Epoetin Beta 11.4.3. Darbepoetin Alfa 11.5. North America Erythropoietin Drugs Market Value Share Analysis, By Drug Type 11.6. North America Erythropoietin Drugs Market Forecast, By Drug Type 11.6.1. Biologics 11.6.2. Biosimilar 11.7. North America Erythropoietin Drugs Market Value Share Analysis, By Drug Application 11.8. North America Erythropoietin Drugs Market Forecast, By Drug Application 11.8.1. Cancer 11.8.2. Renal Disease 11.8.3. Hematology 11.8.4. Neurology 11.8.5. Surgery & Wound Healing 11.9. North America Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 11.10. North America Erythropoietin Drugs Market Forecast, By Distribution Channel 11.10.1. Hospital Pharmacy 11.10.2. Retail Pharmacy 11.10.3. Online Pharmacy 11.11. North America Erythropoietin Drugs Market Value Share Analysis, by Country 11.12. North America Erythropoietin Drugs Market Forecast, by Country 11.12.1. U.S. 11.12.2. Canada 11.13. North America Erythropoietin Drugs Market Analysis, by Country 11.14. U.S. Erythropoietin Drugs Market Forecast, By Drug Class 11.14.1. Epoetin Alfa 11.14.2. Epoetin Beta 11.14.3. Darbepoetin Alfa 11.15. U.S. Erythropoietin Drugs Market Forecast, By Drug Type 11.15.1. Biologics 11.15.2. Biosimilar 11.16. U.S. Erythropoietin Drugs Market Forecast, By Drug Application 11.16.1. Cancer 11.16.2. Renal Disease 11.16.3. Hematology 11.16.4. Neurology 11.16.5. Surgery & Wound Healing 11.17. U.S. Erythropoietin Drugs Market Forecast, By Distribution Channel 11.17.1. Hospital Pharmacy 11.17.2. Retail Pharmacy 11.17.3. Online Pharmacy 11.18. Canada Erythropoietin Drugs Market Forecast, By Drug Class 11.18.1. Epoetin Alfa 11.18.2. Epoetin Beta 11.18.3. Darbepoetin Alfa 11.19. Canada Erythropoietin Drugs Market Forecast, By Drug Type 11.19.1. Biologics 11.19.2. Biosimilar 11.20. Canada Erythropoietin Drugs Market Forecast, By Drug Application 11.20.1. Cancer 11.20.2. Renal Disease 11.20.3. Hematology 11.20.4. Neurology 11.20.5. Surgery & Wound Healing 11.21. Canada Erythropoietin Drugs Market Forecast, By Distribution Channel 11.21.1. Hospital Pharmacy 11.21.2. Retail Pharmacy 11.21.3. Online Pharmacy 11.22. North America Erythropoietin Drugs Market Attractiveness Analysis 11.22.1. By Drug Class 11.22.2. By Drug Type 11.22.3. By Drug Application 11.22.4. By Distribution Channel 11.23. PEST Analysis 11.24. Key Trends 11.24.1. Key Developments 12. Europe Erythropoietin Drugs Market Analysis 12.1. Key Findings 12.2. Europe Erythropoietin Drugs Market Overview 12.3. Europe Erythropoietin Drugs Market Value Share Analysis, By Drug Class 12.4. Europe Erythropoietin Drugs Market Forecast, By Drug Class 12.4.1. Epoetin Alfa 12.4.2. Epoetin Beta 12.4.3. Darbepoetin Alfa 12.5. Europe Erythropoietin Drugs Market Value Share Analysis, By Drug Type 12.6. Europe Erythropoietin Drugs Market Forecast, By Drug Type 12.6.1. Biologics 12.6.2. Biosimilar 12.7. Europe Erythropoietin Drugs Market Value Share Analysis, By Drug Application 12.8. Europe Erythropoietin Drugs Market Forecast, By Drug Application 12.8.1. Cancer 12.8.2. Renal Disease 12.8.3. Hematology 12.8.4. Neurology 12.8.5. Surgery & Wound Healing 12.9. Europe Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 12.10. Europe Erythropoietin Drugs Market Forecast, By Distribution Channel 12.10.1. Hospital Pharmacy 12.10.2. Retail Pharmacy 12.10.3. Online Pharmacy 12.11. Europe Erythropoietin Drugs Market Value Share Analysis, by Country 12.12. Europe Erythropoietin Drugs Market Forecast, by Country 12.12.1. Germany 12.12.2. U.K. 12.12.3. France 12.12.4. Italy 12.12.5. Spain 12.12.6. Rest of Europe 12.13. Europe Erythropoietin Drugs Market Analysis, by Country/ Sub-region 12.14. Germany Erythropoietin Drugs Market Forecast, By Drug Class 12.14.1. Epoetin Alfa 12.14.2. Epoetin Beta 12.14.3. Darbepoetin Alfa 12.15. Germany Erythropoietin Drugs Market Forecast, By Drug Type 12.15.1. Biologics 12.15.2. Biosimilar 12.16. Germany Erythropoietin Drugs Market Forecast, By Drug Application 12.16.1. Cancer 12.16.2. Renal Disease 12.16.3. Hematology 12.16.4. Neurology 12.16.5. Surgery & Wound Healing 12.17. Germany Erythropoietin Drugs Market Forecast, By Distribution Channel 12.17.1. Hospital Pharmacy 12.17.2. Retail Pharmacy 12.17.3. Online Pharmacy 12.18. U.K. Erythropoietin Drugs Market Forecast, By Drug Class 12.18.1. Epoetin Alfa 12.18.2. Epoetin Beta 12.18.3. Darbepoetin Alfa 12.19. U.K. Erythropoietin Drugs Market Forecast, By Drug Type 12.19.1. Biologics 12.19.2. Biosimilar 12.20. U.K. Erythropoietin Drugs Market Forecast, By Drug Application 12.20.1. Cancer 12.20.2. Renal Disease 12.20.3. Hematology 12.20.4. Neurology 12.20.5. Surgery & Wound Healing 12.21. U.K. Erythropoietin Drugs Market Forecast, By Distribution Channel 12.21.1. Hospital Pharmacy 12.21.2. Retail Pharmacy 12.21.3. Online Pharmacy 12.22. France Erythropoietin Drugs Market Forecast, By Drug Class 12.22.1. Epoetin Alfa 12.22.2. Epoetin Beta 12.22.3. Darbepoetin Alfa 12.23. France Erythropoietin Drugs Market Forecast, By Drug Type 12.23.1. Biologics 12.23.2. Biosimilar 12.24. France Erythropoietin Drugs Market Forecast, By Drug Application 12.24.1. Cancer 12.24.2. Renal Disease 12.24.3. Hematology 12.24.4. Neurology 12.24.5. Surgery & Wound Healing 12.25. France Erythropoietin Drugs Market Forecast, By Distribution Channel 12.25.1. Hospital Pharmacy 12.25.2. Retail Pharmacy 12.25.3. Online Pharmacy 12.26. Italy Erythropoietin Drugs Market Forecast, By Drug Class 12.26.1. Epoetin Alfa 12.26.2. Epoetin Beta 12.26.3. Darbepoetin Alfa 12.27. Italy Erythropoietin Drugs Market Forecast, By Drug Type 12.27.1. Biologics 12.27.2. Biosimilar 12.28. Italy Erythropoietin Drugs Market Forecast, By Drug Application 12.28.1. Cancer 12.28.2. Renal Disease 12.28.3. Hematology 12.28.4. Neurology 12.28.5. Surgery & Wound Healing 12.29. Italy Erythropoietin Drugs Market Forecast, By Distribution Channel 12.29.1. Hospital Pharmacy 12.29.2. Retail Pharmacy 12.29.3. Online Pharmacy 12.30. Spain Erythropoietin Drugs Market Forecast, By Drug Class 12.30.1. Epoetin Alfa 12.30.2. Epoetin Beta 12.30.3. Darbepoetin Alfa 12.31. Spain Erythropoietin Drugs Market Forecast, By Drug Type 12.31.1. Biologics 12.31.2. Biosimilar 12.32. Spain Erythropoietin Drugs Market Forecast, By Drug Application 12.32.1. Cancer 12.32.2. Renal Disease 12.32.3. Hematology 12.32.4. Neurology 12.32.5. Surgery & Wound Healing 12.33. Spain Erythropoietin Drugs Market Forecast, By Distribution Channel 12.33.1. Hospital Pharmacy 12.33.2. Retail Pharmacy 12.33.3. Online Pharmacy 12.34. Rest of Europe Erythropoietin Drugs Market Forecast, By Drug Class 12.34.1. Epoetin Alfa 12.34.2. Epoetin Beta 12.34.3. Darbepoetin Alfa 12.35. Rest of Europe Erythropoietin Drugs Market Forecast, By Drug Type 12.35.1. Biologics 12.35.2. Biosimilar 12.36. Rest of Europe Erythropoietin Drugs Market Forecast, By Drug Application 12.36.1. Cancer 12.36.2. Renal Disease 12.36.3. Hematology 12.36.4. Neurology 12.36.5. Surgery & Wound Healing 12.37. Rest Of Europe Erythropoietin Drugs Market Forecast, By Distribution Channel 12.37.1. Hospital Pharmacy 12.37.2. Retail Pharmacy 12.37.3. Online Pharmacy 12.38. Europe Erythropoietin Drugs Market Attractiveness Analysis 12.38.1. By Drug Class 12.38.2. By Drug Type 12.38.3. By Drug Application 12.38.4. By Distribution Channel 12.39. PEST Analysis 12.40. Key Trends 12.40.1. Key Developments 13. Asia Pacific Erythropoietin Drugs Market Analysis 13.1. Key Findings 13.2. Asia Pacific Erythropoietin Drugs Market Overview 13.3. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, By Drug Class 13.4. Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Class 13.4.1. Epoetin Alfa 13.4.2. Epoetin Beta 13.4.3. Darbepoetin Alfa 13.5. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, By Drug Type 13.6. Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Type 13.6.1. Biologics 13.6.2. Biosimilar 13.7. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, By Drug Application 13.8. Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Application 13.8.1. Cancer 13.8.2. Renal Disease 13.8.3. Hematology 13.8.4. Neurology 13.8.5. Surgery & Wound Healing 13.9. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 13.10. Asia Pacific Erythropoietin Drugs Market Forecast, By Distribution Channel 13.10.1. Hospital Pharmacy 13.10.2. Retail Pharmacy 13.10.3. Online Pharmacy 13.11. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Country 13.12. Asia Pacific Erythropoietin Drugs Market Forecast, by Country 13.12.1. China 13.12.2. India 13.12.3. Japan 13.12.4. ASEAN 13.12.5. Rest of Asia Pacific 13.13. Asia Pacific Erythropoietin Drugs Market Analysis, by Country/ Sub-region 13.14. China Erythropoietin Drugs Market Forecast, By Drug Class 13.14.1. Epoetin Alfa 13.14.2. Epoetin Beta 13.14.3. Darbepoetin Alfa 13.15. China Erythropoietin Drugs Market Forecast, By Drug Type 13.15.1. Biologics 13.15.2. Biosimilar 13.16. China Erythropoietin Drugs Market Forecast, By Drug Application 13.16.1. Cancer 13.16.2. Renal Disease 13.16.3. Hematology 13.16.4. Neurology 13.16.5. Surgery & Wound Healing 13.17. China Erythropoietin Drugs Market Forecast, By Distribution Channel 13.17.1. Hospital Pharmacy 13.17.2. Retail Pharmacy 13.17.3. Online Pharmacy 13.18. India Erythropoietin Drugs Market Forecast, By Drug Class 13.18.1. Epoetin Alfa 13.18.2. Epoetin Beta 13.18.3. Darbepoetin Alfa 13.19. India Erythropoietin Drugs Market Forecast, By Drug Type 13.19.1. Biologics 13.19.2. Biosimilar 13.20. India Erythropoietin Drugs Market Forecast, By Drug Application 13.20.1. Cancer 13.20.2. Renal Disease 13.20.3. Hematology 13.20.4. Neurology 13.20.5. Surgery & Wound Healing 13.21. India Erythropoietin Drugs Market Forecast, By Distribution Channel 13.21.1. Hospital Pharmacy 13.21.2. Retail Pharmacy 13.21.3. Online Pharmacy 13.22. Japan Erythropoietin Drugs Market Forecast, By Drug Class 13.22.1. Epoetin Alfa 13.22.2. Epoetin Beta 13.22.3. Darbepoetin Alfa 13.23. Japan Erythropoietin Drugs Market Forecast, By Drug Type 13.23.1. Biologics 13.23.2. Biosimilar 13.24. Japan Erythropoietin Drugs Market Forecast, By Drug Application 13.24.1. Cancer 13.24.2. Renal Disease 13.24.3. Hematology 13.24.4. Neurology 13.24.5. Surgery & Wound Healing 13.25. Japan Erythropoietin Drugs Market Forecast, By Distribution Channel 13.25.1. Hospital Pharmacy 13.25.2. Retail Pharmacy 13.25.3. Online Pharmacy 13.26. ASEAN Erythropoietin Drugs Market Forecast, By Drug Class 13.26.1. Epoetin Alfa 13.26.2. Epoetin Beta 13.26.3. Darbepoetin Alfa 13.27. ASEAN Erythropoietin Drugs Market Forecast, By Drug Type 13.27.1. Biologics 13.27.2. Biosimilar 13.28. ASEAN Erythropoietin Drugs Market Forecast, By Drug Application 13.28.1. Cancer 13.28.2. Renal Disease 13.28.3. Hematology 13.28.4. Neurology 13.28.5. Surgery & Wound Healing 13.29. ASEAN Erythropoietin Drugs Market Forecast, By Distribution Channel 13.29.1. Hospital Pharmacy 13.29.2. Retail Pharmacy 13.29.3. Online Pharmacy 13.30. Rest of Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Class 13.30.1. Epoetin Alfa 13.30.2. Epoetin Beta 13.30.3. Darbepoetin Alfa 13.31. Rest of Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Type 13.31.1. Biologics 13.31.2. Biosimilar 13.32. Rest of Asia Pacific Erythropoietin Drugs Market Forecast, By Drug Application 13.32.1. Cancer 13.32.2. Renal Disease 13.32.3. Hematology 13.32.4. Neurology 13.32.5. Surgery & Wound Healing 13.33. Rest of Asia Pacific Erythropoietin Drugs Market Forecast, By Distribution Channel 13.33.1. Hospital Pharmacy 13.33.2. Retail Pharmacy 13.33.3. Online Pharmacy 13.34. Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis 13.34.1. By Drug Class 13.34.2. By Drug Type 13.34.3. By Drug Application 13.34.4. By Distribution Channel 13.35. PEST Analysis 13.36. Key Trends 13.36.1. Key Developments 14. Middle East & Africa Erythropoietin Drugs Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Erythropoietin Drugs Market Overview 14.3. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, By Drug Class 14.4. Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Class 14.4.1. Epoetin Alfa 14.4.2. Epoetin Beta 14.4.3. Darbepoetin Alfa 14.5. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, By Drug Type 14.6. Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Type 14.6.1. Biologics 14.6.2. Biosimilar 14.7. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, By Drug Application 14.8. Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Application 14.8.1. Cancer 14.8.2. Renal Disease 14.8.3. Hematology 14.8.4. Neurology 14.8.5. Surgery & Wound Healing 14.9. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 14.10. Middle East & Africa Erythropoietin Drugs Market Forecast, By Distribution Channel 14.10.1. Hospital Pharmacy 14.10.2. Retail Pharmacy 14.10.3. Online Pharmacy 14.11. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Country 14.12. Middle East & Africa Erythropoietin Drugs Market Forecast, by Country 14.12.1. GCC 14.12.2. South Africa 14.12.3. Rest of Middle East & Africa 14.13. Middle East & Africa Erythropoietin Drugs Market Analysis, by Country/ Sub-region 14.14. GCC Erythropoietin Drugs Market Forecast, By Drug Class 14.14.1. Epoetin Alfa 14.14.2. Epoetin Beta 14.14.3. Darbepoetin Alfa 14.15. GCC Erythropoietin Drugs Market Forecast, By Drug Type 14.15.1. Biologics 14.15.2. Biosimilar 14.16. GCC Erythropoietin Drugs Market Forecast, By Drug Application 14.16.1. Cancer 14.16.2. Renal Disease 14.16.3. Hematology 14.16.4. Neurology 14.16.5. Surgery & Wound Healing 14.17. GCC Erythropoietin Drugs Market Forecast, By Distribution Channel 14.18. Hospital Pharmacy 14.19. Retail Pharmacy 14.20. Online Pharmacy 14.21. Others South Africa Erythropoietin Drugs Market Forecast, By Drug Class 14.21.1. Epoetin Alfa 14.21.2. Epoetin Beta 14.21.3. Darbepoetin Alfa 14.22. South Africa Erythropoietin Drugs Market Forecast, By Drug Type 14.22.1. Biologics 14.22.2. Biosimilar 14.23. South Africa Erythropoietin Drugs Market Forecast, By Drug Application 14.23.1. Cancer 14.23.2. Renal Disease 14.23.3. Hematology 14.23.4. Neurology 14.23.5. Surgery & Wound Healing 14.24. South Africa Erythropoietin Drugs Market Forecast, By Distribution Channel 14.24.1. Hospital Pharmacy 14.24.2. Retail Pharmacy 14.24.3. Online Pharmacy 14.25. Rest of Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Class 14.25.1. Epoetin Alfa 14.25.2. Epoetin Beta 14.25.3. Darbepoetin Alfa 14.26. Rest of Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Type 14.26.1. Biologics 14.26.2. Biosimilar 14.27. Rest of Middle East & Africa Erythropoietin Drugs Market Forecast, By Drug Application 14.27.1. Cancer 14.27.2. Renal Disease 14.27.3. Hematology 14.27.4. Neurology 14.27.5. Surgery & Wound Healing 14.28. Rest of Middle East & Africa Erythropoietin Drugs Market Forecast, By Distribution Channel 14.28.1. Hospital Pharmacy 14.28.2. Retail Pharmacy 14.28.3. Online Pharmacy 14.29. Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis 14.29.1. By Drug Class 14.29.2. By Drug Type 14.29.3. By Drug Application 14.29.4. By Distribution Channel 14.30. PEST Analysis 14.31. Key Trends 14.31.1. Key Developments 15. South America Erythropoietin Drugs Market Analysis 15.1. Key Findings 15.2. South America Erythropoietin Drugs Market Overview 15.3. South America Erythropoietin Drugs Market Value Share Analysis, By Drug Class 15.4. South America Erythropoietin Drugs Market Forecast, By Drug Class 15.4.1. Epoetin Alfa 15.4.2. Epoetin Beta 15.4.3. Darbepoetin Alfa 15.5. South America Erythropoietin Drugs Market Value Share Analysis, By Drug Type 15.6. South America Erythropoietin Drugs Market Forecast, By Drug Type 15.6.1. Biologics 15.6.2. Biosimilar 15.7. South America Erythropoietin Drugs Market Value Share Analysis, By Drug Application 15.8. South America Erythropoietin Drugs Market Forecast, By Drug Application 15.8.1. Cancer 15.8.2. Renal Disease 15.8.3. Hematology 15.8.4. Neurology 15.8.5. Surgery & Wound Healing 15.9. South America Erythropoietin Drugs Market Value Share Analysis, By Distribution Channel 15.10. South America Erythropoietin Drugs Market Forecast, By Distribution Channel 15.10.1. Hospital Pharmacy 15.10.2. Retail Pharmacy 15.10.3. Online Pharmacy 15.11. South America Erythropoietin Drugs Market Value Share Analysis, by Country 15.12. South America Erythropoietin Drugs Market Forecast, by Country 15.12.1. Brazil 15.12.2. Mexico 15.12.3. Rest of South America 15.13. South America Erythropoietin Drugs Market Analysis, by Country/ Sub-region 15.14. Brazil Erythropoietin Drugs Market Forecast, By Drug Class 15.14.1. Epoetin Alfa 15.14.2. Epoetin Beta 15.14.3. Darbepoetin Alfa 15.15. Brazil Erythropoietin Drugs Market Forecast, By Drug Type 15.15.1. Biologics 15.15.2. Biosimilar 15.16. Brazil Erythropoietin Drugs Market Forecast, By Drug Application 15.16.1. Cancer 15.16.2. Renal Disease 15.16.3. Hematology 15.16.4. Neurology 15.16.5. Surgery & Wound Healing 15.17. Brazil Erythropoietin Drugs Market Forecast, By Distribution Channel 15.17.1. Hospital Pharmacy 15.17.2. Retail Pharmacy 15.17.3. Online Pharmacy 15.18. Mexico Erythropoietin Drugs Market Forecast, By Drug Class 15.18.1. Epoetin Alfa 15.18.2. Epoetin Beta 15.18.3. Darbepoetin Alfa 15.19. Mexico Erythropoietin Drugs Market Forecast, By Drug Type 15.19.1. Biologics 15.19.2. Biosimilar 15.20. Mexico Erythropoietin Drugs Market Forecast, By Drug Application 15.20.1. Cancer 15.20.2. Renal Disease 15.20.3. Hematology 15.20.4. Neurology 15.20.5. Surgery & Wound Healing 15.21. Mexico Erythropoietin Drugs Market Forecast, By Distribution Channel 15.21.1. Hospital Pharmacy 15.21.2. Retail Pharmacy 15.21.3. Online Pharmacy 15.22. Rest of South America Erythropoietin Drugs Market Forecast, By Drug Class 15.22.1. Epoetin Alfa 15.22.2. Epoetin Beta 15.22.3. Darbepoetin Alfa 15.23. Rest of South America Erythropoietin Drugs Market Forecast, By Drug Type 15.23.1. Biologics 15.23.2. Biosimilar 15.24. Rest of South America Erythropoietin Drugs Market Forecast, By Drug Application 15.24.1. Cancer 15.24.2. Renal Disease 15.24.3. Hematology 15.24.4. Neurology 15.24.5. Surgery & Wound Healing 15.25. Rest of South America Erythropoietin Drugs Market Forecast, By Distribution Channel 15.25.1. Hospital Pharmacy 15.25.2. Retail Pharmacy 15.25.3. Online Pharmacy 15.26. South America Erythropoietin Drugs Market Attractiveness Analysis 15.26.1. By Drug Class 15.26.2. By Drug Type 15.26.3. By Drug Application 15.26.4. By Distribution Channel 15.27. PEST Analysis 15.28. Key Trends 15.28.1. Key Developments 16. Company Landscape 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.3. Competitive Benchmarking of Company and Services 16.4. Company Profiles: Key Players 16.4.1. 3SBio 16.4.1.1. Company Overview 16.4.1.2. Financial Overview 16.4.1.3. Business Strategy 16.4.1.4. Recent Developments 16.4.1.5. Development Footprint 16.4.2. Amgen 16.4.3. Hoffmann-LA Roche 16.4.4. Johnson & Johnson 16.4.5. Kyowa Hakko Kirin 16.4.6. Ahua Pharmaceutical 16.4.7. BIOSIDUS 16.4.8. Biocon 16.4.9. Boehringer Ingelheim 16.4.10. Chugai Pharmaceutical 16.4.11. Celltrion 16.4.12. Intas Pharmaceuticals 16.4.13. Cipla 16.4.14. DAICHI SANKYO 16.4.15. Dr. Reddy's Laboratories 16.4.16. Teva Pharmaceutical Industries 16.4.17. Dragon Pharma 16.4.18. Huaxin High Biotechnology 16.4.19. JCR Pharmaceuticals 16.4.20. Shanghai Kehua Bio-Engineering 16.4.21. LG Life Science 16.4.22. Novartis 16.4.23. Pfizer 16.4.24. Sandoz International 16.4.25. Shenyang Sunshine Pharmaceutical 16.4.26. Shenzhen Sai Bao Er Bio-Pharmaceutical 16.4.27. Sihuan Pharmaceutical 16.4.28. STADA 16.4.29. Uni-Bio Science 16.4.30. Wanbang Biochemical Pharmaceuticals 17. Primary Key Insights